Literature DB >> 1892757

Cis dichlorodiammine platinum induced DNA interstrand cross-links in primary cultures of human ovarian cancer.

G Balconi1, Y Pang, M Broggini, F Morali, M Marzola, E Erba, M Ponti, L Spinelli, C Mangioni, L Redaelli.   

Abstract

We quantified and examined the kinetics of DNA interstrand cross links (DNA-ISC) caused by Cis dichlorodiammine platinum (DDP) using the method of alkaline elution in 58 highly purified human ovarian tumours growing in primary culture. A large heterogeneity in both the quantity and kinetics of DDP induced DNA-ISC was observed in cultures derived from neoplasms of different patients and from different lesions of the same patient. In the majority of cases. DNA-ISC lasted for prolonged time intervals after 1 h drug exposure, being significantly repaired only 48 or 72 h following drug washout. The persistence of DNA-ISC is probably due to a prolonged formation of these lesions for up to 24 h as assessed by the change in the repair kinetics that occurred after preventing new DNA-ISC formation by quenching of monoadducts with thiourea. The inefficient repair of DDP monoadducts appears therefore to be a possible reason for the permanence of DNA-ISC. These studies suggest that the long permanence of DNA-ISC in human ovarian cancer could be the basis for the high selectivity of DDP for this human malignancy.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1892757      PMCID: PMC1977530          DOI: 10.1038/bjc.1991.293

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  29 in total

1.  Differential repair of platinum-DNA adducts in human bladder and testicular tumor continuous cell lines.

Authors:  P Bedford; A M Fichtinger-Schepman; S A Shellard; M C Walker; J R Masters; B T Hill
Journal:  Cancer Res       Date:  1988-06-01       Impact factor: 12.701

Review 2.  DNA repair enzymes.

Authors:  A Sancar; G B Sancar
Journal:  Annu Rev Biochem       Date:  1988       Impact factor: 23.643

3.  Monoclonal antibodies to DNA modified with cis- or trans-diamminedichloroplatinum(II).

Authors:  W I Sundquist; S J Lippard; B D Stollar
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

4.  Comparison of the interaction of cis- and trans-diamminedichloroplatinum(II) with DNA by a simple filter binding assay.

Authors:  A Eastman
Journal:  Biochem Biophys Res Commun       Date:  1982-04-14       Impact factor: 3.575

5.  Effect of thiourea on survival and DNA cross-link formation in cells treated with platinum(II) complexes, L-phenylalanine mustard, and bis(2-chloroethyl)methylamine.

Authors:  L A Zwelling; J Filipski; K W Kohn
Journal:  Cancer Res       Date:  1979-12       Impact factor: 12.701

6.  Formation and repair of cisplatin-induced adducts to DNA in cultured normal and repair-deficient human fibroblasts.

Authors:  F J Dijt; A M Fichtinger-Schepman; F Berends; J Reedijk
Journal:  Cancer Res       Date:  1988-11-01       Impact factor: 12.701

7.  Human ovarian tumors in primary culture: growth, characterization and initial evaluation of the response to cis platinum treatment in vitro.

Authors:  G Balconi; M Broggini; E Erba; M D'Incalci; N Colombo; C Mangioni; F Bertolero
Journal:  Int J Cancer       Date:  1988-06-15       Impact factor: 7.396

8.  Cancer of the ovary: a summary of experience with cis-dichlorodiammineplatinum(II) at the Royal Marsden Hospital.

Authors:  E Wiltshaw; S Subramarian; C Alexopoulos; G H Barker
Journal:  Cancer Treat Rep       Date:  1979 Sep-Oct

9.  Heterogeneity of glutathione content in human ovarian cancer.

Authors:  F Y Lee; A Vessey; E Rofstad; D W Siemann; R M Sutherland
Journal:  Cancer Res       Date:  1989-10-01       Impact factor: 12.701

10.  Cis-diamminedichloroplatinum, vinblastine, and bleomycin combination chemotherapy in disseminated testicular cancer.

Authors:  L H Einhorn; J Donohue
Journal:  Ann Intern Med       Date:  1977-09       Impact factor: 25.391

View more
  2 in total

Review 1.  Review of Cisplatin and oxaliplatin in current immunogenic and monoclonal antibody treatments.

Authors:  Rao Khalid Mehmood
Journal:  Oncol Rev       Date:  2014-09-23

Review 2.  Review of Cisplatin and Oxaliplatin in Current Immunogenic and Monoclonal Antibodies Perspective.

Authors:  Rao Khalid Mehmood; Jody Parker; Shakil Ahmed; Eyas Qasem; Ahmed A Mohammed; Muhammed Zeeshan; Ernest Jehangir
Journal:  World J Oncol       Date:  2014-06-25
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.